US Map / Oregon
State OR

Clinical Trials in Oregon

Oregon is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Oregon and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 195 actively recruiting studies with Oregon sites out of 195 registered in total. The busiest research areas in Oregon are Breast Cancer, Endometrial Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include Oregon Health and Science University, National Cancer Institute (NCI), VA Office of Research and Development. By stage, Oregon trials break down as Phase 1 (25), Phase 2 (49), Phase 3 (55), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
195
Recruiting Now
195
← Back to US Map
Top Conditions in Oregon
Breast Cancer (7)Endometrial Cancer (6)Advanced Solid Tumor (5)Ovarian Cancer (4)Colorectal Cancer (4)Multiple Myeloma (4)Metastatic Solid Tumor (3)Cancer (3)Lung Cancer (3)Prostate Cancer (3)Thyroid Cancer (3)NSCLC (Non-small Cell Lung Cancer) (3)

Frequently Asked Questions — Clinical Trials in Oregon

How many clinical trials are currently recruiting in Oregon?
ClinicalMetric currently tracks 195 actively recruiting clinical trials with at least one location in Oregon. The total number of registered studies—including active but not currently enrolling trials—is 195. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Oregon?
Oregon hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Endometrial Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Oregon serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Oregon?
To join a clinical trial in Oregon, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Oregon maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Oregon

NCT06775106 N/A
Recruiting
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases an...
Condition
Pulmonary Disease
Enrollment
100 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT07484217 Phase 3
Recruiting
Clinical Assessment of Response in the Treatment of Depression With Daytime Slee...
Condition
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Enrollment
508 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT06872684 N/A
Recruiting
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Sur...
Condition
Aneurysm
Enrollment
183 pts
Location
United States
Sponsor
Stryker Neurovascular
View Trial →
NCT06667908 Phase 2
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolida...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Johnson & Johnson Enterprise I
View Trial →
NCT07432490 Phase 2
Recruiting
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 De...
Condition
Glut1 Deficiency
Enrollment
16 pts
Location
United States
Sponsor
Oregon Health and Science Univ
View Trial →
NCT04486352 Phase 1, Phase 2
Recruiting
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial...
Condition
Endometrial Cancer
Enrollment
148 pts
Location
United States
Sponsor
Alliance Foundation Trials, LL
View Trial →
NCT07055633 N/A
Recruiting
Improving Cognitive Rehabilitation Outcomes
Condition
Mild Traumatic Brain Injury
Enrollment
144 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06337318 Phase 3
Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor ...
Condition
Classic Follicular Lymphoma
Enrollment
600 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04343313 N/A
Recruiting
The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study
Condition
Mitral Valve Insufficiency
Enrollment
30 pts
Location
United States
Sponsor
Half Moon Medical
View Trial →
NCT06524882 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Condition
Amblyopia
Enrollment
252 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06827262 N/A
Recruiting
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Condition
Chronic Low-back Pain
Enrollment
1,500 pts
Location
United States
Sponsor
Boston Scientific Corporation
View Trial →
NCT05643859 N/A
Recruiting
Impact of Dietary Fiber Supplementation on Colonic Microbiome
Condition
Benign Colorectal Neoplasm
Enrollment
120 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
View Trial →
NCT07194070 N/A
Recruiting
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Regi...
Condition
Hemolytic Disease of the Fetus and Newborn
Enrollment
175 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT02432560 N/A
Recruiting
Safety and Durability of Sirolimus for Treatment of LAM
Condition
Lymphangioleiomyomatosis
Enrollment
600 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT05807854 N/A
Recruiting
RSA Vs RCR for Massive RCTs
Condition
Rotator Cuff Tears
Enrollment
160 pts
Location
United States, Switzerland
Sponsor
La Tour Hospital
View Trial →
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT07553429 Phase 1, Phase 2
Recruiting
A Study in People With Diabetic Macular Edema to Test How Well Different Doses o...
Condition
Diabetic Macular Edema
Enrollment
49 pts
Location
United States, Puerto Rico
Sponsor
Boehringer Ingelheim
View Trial →
NCT06193928 N/A
Recruiting
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United Sta...
Condition
Alagille Syndrome
Enrollment
70 pts
Location
United States
Sponsor
Mirum Pharmaceuticals, Inc.
View Trial →
NCT06160128 N/A
Recruiting
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System...
Condition
COVID-19, SARS-CoV-2 Infection
Enrollment
400,000 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT05355701 Phase 1
Recruiting
A Study to Learn About the Study Medicine Called PF-07799933 in People With Adva...
Condition
Melanoma
Enrollment
267 pts
Location
United States, Canada, Israel
Sponsor
Pfizer
View Trial →
NCT05813678 N/A
Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALac...
Condition
Phenylketonuria (PKU)
Enrollment
450 pts
Location
United States, Germany, Italy
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
590 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
View Trial →
Page 3 of 8 — 195 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology